Carbutamide

File:Carbutamide.svg

Carbutamide is a sulfonylurea drug used in the treatment of type 2 diabetes mellitus. It was one of the first oral antidiabetic agents to be developed and is part of the first generation of sulfonylureas.

Mechanism of Action

Carbutamide works by stimulating the release of insulin from the beta cells of the pancreas. It binds to the sulfonylurea receptor on the beta cells, leading to the closure of ATP-sensitive potassium channels. This results in the depolarization of the cell membrane and the opening of voltage-gated calcium channels, which increases intracellular calcium and triggers insulin secretion.

Pharmacokinetics

Carbutamide is absorbed from the gastrointestinal tract and metabolized in the liver. It is excreted primarily through the kidneys. The drug has a relatively short half-life, which necessitates multiple doses throughout the day to maintain effective blood glucose control.

Side Effects

Common side effects of carbutamide include hypoglycemia, nausea, and gastrointestinal disturbances. Less common but more serious side effects can include hematological disorders such as leukopenia and thrombocytopenia.

History

Carbutamide was developed in the mid-20th century as one of the first oral treatments for diabetes. It paved the way for the development of other sulfonylureas and oral antidiabetic medications.

See Also

• Diabetes mellitus
• Sulfonylurea
• Insulin
• Hypoglycemia